(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 8.41% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Albemarle's revenue in 2026 is $5,494,583,000.On average, 26 Wall Street analysts forecast ALB's revenue for 2026 to be $740,629,608,280, with the lowest ALB revenue forecast at $626,940,604,716, and the highest ALB revenue forecast at $926,848,422,209. On average, 24 Wall Street analysts forecast ALB's revenue for 2027 to be $770,349,140,332, with the lowest ALB revenue forecast at $605,712,367,536, and the highest ALB revenue forecast at $1,009,756,481,862.
In 2028, ALB is forecast to generate $832,972,440,013 in revenue, with the lowest revenue forecast at $593,447,163,832 and the highest revenue forecast at $1,178,049,228,839.